LENZ - LENZ Therapeutics, Inc.

QQQ $ 629.16 $ 3.02 (0.48 %)

DIA $ 475.58 $ 0.66 (0.14 %)

SPY $ 681.80 $ 2.23 (0.33 %)

TLT $ 90.21 $ -0.27 (-0.3 %)

GLD $ 368.20 $ -2.01 (-0.54 %)

Previous Close

$ 29.72

Open

$ 30.84

Bid

$ 29.75 x 10

Ask

$ 32.89 x 100

Day's Range

$ 29.55 - $ 32.00

52 Week Range

$ 16.54 - $ 50.40

Volume

840,525

Average Volume

Market Cap

847.68M

Beta (5Y Monthly)

$ 1.68

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-30-2025	06-30-2025	10-Q
2	05-07-2025	03-31-2025	10-Q
3	03-19-2025	12-31-2024	10-K
4	11-06-2024	09-30-2024	10-Q
5	08-14-2024	06-30-2024	10-Q
6	05-08-2024	03-31-2024	10-Q
7	02-27-2024	12-31-2023	10-K
8	11-13-2023	09-30-2023	10-Q
9	08-14-2023	06-30-2023	10-Q
10	05-11-2023	03-31-2023	10-Q
11	03-20-2023	12-31-2022	10-K
12	11-09-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	03-21-2022	12-31-2021	10-K
16	11-10-2021	09-30-2021	10-Q
17	08-12-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Raymond James Reiterates Outperform on LEN...
10/20/2025 17:18:26

Raymond James analyst Gary Nachman reiterates LENZ Therapeutics (NASDAQ:LENZ) with a Outperform and raises the price target ...

Piper Sandler Maintains Overweight on LENZ...
10/10/2025 12:52:39

Piper Sandler analyst Biren Amin maintains LENZ Therapeutics (NASDAQ:LENZ) with a Overweight and raises the price target fro...

LENZ Therapeutics' VIZZ Commercially Avail...
09/30/2025 12:06:37

VIZZ sample distribution initiated nationwide to Eye Care ProfessionalsCommercial product shipments to be initiated in October ...

12 Health Care Stocks Moving In Monday's P...
08/11/2025 12:08:21

why-international-money-express-shares-are-trading-higher-by-around-54-here-are-20-stocks-moving-premarket

Why International Money Express Shares Are...
08/11/2025 09:22:11

Citigroup Maintains Buy on LENZ Therapeuti...
08/01/2025 19:53:01

Citigroup analyst Yigal Nochomovitz maintains LENZ Therapeutics (NASDAQ:LENZ) with a Buy and raises the price target from $4...

HC Wainwright & Co. Maintains Buy on LENZ ...
08/01/2025 17:24:32

HC Wainwright & Co. analyst Matthew Caufield maintains LENZ Therapeutics (NASDAQ:LENZ) with a Buy and raises the price t...

lenz-therapeutics-eye-drop-scores-first-fda-approval-for-age-related-blurred-vision-condition-impacting-128-million-people

LENZ Therapeutics' Eye Drop Scores First F...
08/01/2025 14:25:51

LENZ Therapeutics' VIZZ earns FDA approval as the first aceclidine-based eye drop to treat presbyopia, with U.S. launch exp...

Citigroup Maintains Buy on LENZ Therapeuti...
07/31/2025 23:07:57

Citigroup analyst Yigal Nochomovitz maintains LENZ Therapeutics (NASDAQ:LENZ) with a Buy and raises the price target from $4...

Trading Halt: Halt status updated at 4:20:...
07/31/2025 20:20:09

LENZ Therapeutics Wins FDA Approval For VI...
07/31/2025 20:15:11

VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition imp...

Trading Halt: Halted at 4:01:07 p.m. ET - ...
07/31/2025 20:02:25

Raymond James Maintains Outperform on LENZ...
07/31/2025 14:31:18

Raymond James analyst Gary Nachman maintains LENZ Therapeutics (NASDAQ:LENZ) with a Outperform and raises the price target f...

LENZ Therapeutics Q2 EPS $(0.53) Beats $(0...
07/30/2025 12:11:48

LENZ Therapeutics (NASDAQ:LENZ) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0...

ENZ Therapeutics Says CORXEL Submits NDA F...
07/28/2025 12:06:47

LENZ Therapeutics, Inc. (NASDAQ:LENZ, "LENZ" or the "Company"))), a pre-commercial stage biopharmaceutical comp...

HC Wainwright & Co. Maintains Buy on LENZ ...
07/28/2025 10:15:16

HC Wainwright & Co. analyst Matthew Caufield maintains LENZ Therapeutics (NASDAQ:LENZ) with a Buy and raises the price t...

LENZ Therapeutics And Laboratoires Théa An...
07/07/2025 12:05:50

LENZ Therapeutics, Inc. (NASDAQ:LENZ) and Laboratoires Théa ("Théa") announced an exclusive license and commercializati...

LENZ Therapeutics And Lotus Pharmaceutical...
05/09/2025 13:06:32

HC Wainwright & Co. Reiterates Buy on LENZ...
05/08/2025 10:37:21

HC Wainwright & Co. analyst Matthew Caufield reiterates LENZ Therapeutics (NASDAQ:LENZ) with a Buy and maintains $38 pri...

LENZ Therapeutics Q1 EPS $(0.53) Beats $(0...
05/07/2025 20:17:15

LENZ Therapeutics (NASDAQ:LENZ) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0...